Difference between revisions of "Team:EPF Lausanne/Basic Part"
E.Cuillery (Talk | contribs) |
E.Cuillery (Talk | contribs) |
||
| Line 25: | Line 25: | ||
<div class="col-md-6"> | <div class="col-md-6"> | ||
| − | + | <br><br><br> | |
<h2>PAM rich URS J23117Alt promoter</h2> | <h2>PAM rich URS J23117Alt promoter</h2> | ||
</div> | </div> | ||
| Line 36: | Line 36: | ||
</div> | </div> | ||
| − | + | ||
| − | + | <div class="col-md-12 text-center"> | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | <div class="col-md- | + | |
<font size="100"><h3>Bikard et al. used dCas9-ω targetting the promoter PAM rich URS J23117, BBa_K1723001, in order to regulate gene expression using gRNA (single guide RNA) guided dCas9-ω. By using our own dCas9-ω system we proved that this promoter can be activated or repressed (see <a href="https://2015.igem.org/Team:EPF_Lausanne/Results">results page</a>). Now, on the model of this promoter, we created <b>a new fully synthetic promoter</b>: PAM rich URS J23117Alt promoter, BBa_K1723005. We mutated the sequence of BBa_K1723001 between and outside the -10 and -35 sequence where the RNA polymerase binds (see <a href="https://2015.igem.org/Team:EPF_Lausanne/Results">BBa_K1723005 registry page</a> for more details) in order to have <b>a promoter targeted by a set of sgRNAs different</b> from the sgRNAs aiming for BBa_K1723001. The creation of this part and its experimental validation (see <a href="https://2015.igem.org/Team:EPF_Lausanne/Results">results page</a>) is very promising for us as it is the proof of the MUTABILITY of the targeted promoters. We can now imagine of mutating again the promoter to obtain others promote/sgRNAs sets creating more and more different transistors-like elements in cells. </h3></font> | <font size="100"><h3>Bikard et al. used dCas9-ω targetting the promoter PAM rich URS J23117, BBa_K1723001, in order to regulate gene expression using gRNA (single guide RNA) guided dCas9-ω. By using our own dCas9-ω system we proved that this promoter can be activated or repressed (see <a href="https://2015.igem.org/Team:EPF_Lausanne/Results">results page</a>). Now, on the model of this promoter, we created <b>a new fully synthetic promoter</b>: PAM rich URS J23117Alt promoter, BBa_K1723005. We mutated the sequence of BBa_K1723001 between and outside the -10 and -35 sequence where the RNA polymerase binds (see <a href="https://2015.igem.org/Team:EPF_Lausanne/Results">BBa_K1723005 registry page</a> for more details) in order to have <b>a promoter targeted by a set of sgRNAs different</b> from the sgRNAs aiming for BBa_K1723001. The creation of this part and its experimental validation (see <a href="https://2015.igem.org/Team:EPF_Lausanne/Results">results page</a>) is very promising for us as it is the proof of the MUTABILITY of the targeted promoters. We can now imagine of mutating again the promoter to obtain others promote/sgRNAs sets creating more and more different transistors-like elements in cells. </h3></font> | ||
</div> | </div> | ||
| − | |||
| − | |||
</div> | </div> | ||
Revision as of 01:49, 19 September 2015
Bikard et al. used dCas9-ω targetting the promoter PAM rich URS J23117, BBa_K1723001, in order to regulate gene expression using gRNA (single guide RNA) guided dCas9-ω. By using our own dCas9-ω system we proved that this promoter can be activated or repressed (see results page). Now, on the model of this promoter, we created a new fully synthetic promoter: PAM rich URS J23117Alt promoter, BBa_K1723005. We mutated the sequence of BBa_K1723001 between and outside the -10 and -35 sequence where the RNA polymerase binds (see BBa_K1723005 registry page for more details) in order to have a promoter targeted by a set of sgRNAs different from the sgRNAs aiming for BBa_K1723001. The creation of this part and its experimental validation (see results page) is very promising for us as it is the proof of the MUTABILITY of the targeted promoters. We can now imagine of mutating again the promoter to obtain others promote/sgRNAs sets creating more and more different transistors-like elements in cells.
